Health3 hours ago
Vor Biopharma Prices $100M Offering, Shares Drop 26%
Clinical-stage biotechnology company Vor Biopharma has announced a significant public offering, pricing 10 million shares at $10.00 each. The offering is expected to generate gross proceeds...